TY - JOUR
T1 - Successful liver transplantation as rescue therapy in a patient with metastases from a vasoactive intestinal peptide producing neuroendocrine tumor
AU - Andreassen, Mikkel
AU - Garbyal, Rajendra Singh
AU - Larsen, Peter Nørgaard
AU - Hansen, Carsten Palnæs
AU - Hannibal, Jens
AU - Oturai, Peter
AU - Knigge, Ulrich
AU - Schultz, Nicolai
N1 - Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2024.
PY - 2024/5
Y1 - 2024/5
N2 - This case report presents a 40-year-old patient with a vasoactive intestinal peptide (VIP) secreting high grade (Ki-67 39%) neuroendocrine tumor (NET) from the pancreas, for whom successful liver transplantation (LT) was carried out 8 years after resection of the primary tumor due to massive liver metastases. The transplantation was done as rescue therapy due to rapid progression and a devastating clinical condition requiring intravenous supplementation for 20 hours daily. The latest imaging carried out 18 months after transplantation is without signs of recurrence, and the patient is in good health with undetectable levels of VIP. According to the guidelines, LT is only recommended if Ki-67 is <20% and if there has been tumor control for more than 6 months prior to transplantation. Our case illustrates that LT is an option that should be considered for selected NET patients without extrahepatic involvement regardless of tumor grade and clinical condition.
AB - This case report presents a 40-year-old patient with a vasoactive intestinal peptide (VIP) secreting high grade (Ki-67 39%) neuroendocrine tumor (NET) from the pancreas, for whom successful liver transplantation (LT) was carried out 8 years after resection of the primary tumor due to massive liver metastases. The transplantation was done as rescue therapy due to rapid progression and a devastating clinical condition requiring intravenous supplementation for 20 hours daily. The latest imaging carried out 18 months after transplantation is without signs of recurrence, and the patient is in good health with undetectable levels of VIP. According to the guidelines, LT is only recommended if Ki-67 is <20% and if there has been tumor control for more than 6 months prior to transplantation. Our case illustrates that LT is an option that should be considered for selected NET patients without extrahepatic involvement regardless of tumor grade and clinical condition.
UR - http://www.scopus.com/inward/record.url?scp=85194926928&partnerID=8YFLogxK
U2 - 10.1093/jscr/rjae371
DO - 10.1093/jscr/rjae371
M3 - Journal article
C2 - 38826856
SN - 2042-8812
VL - 2024
SP - rjae371
JO - Journal of Surgical Case Reports
JF - Journal of Surgical Case Reports
IS - 5
M1 - rjae371
ER -